This is your sign to start a simple budget-friendly coffee routine that still hits every time
Key takeaways Cleveland Clinic real-world data presented at ASCO 2026 found patients who started a GLP-1 receptor agonist (semaglutide or tirzepatide) after a breast cancer diagnosis were about 43% less likely to progress to Stage IV disease than patients who started a DPP-4 inhibitor (hazard ratio 0.57, 95% CI 0.46 to 0.71
GLP-1 ELISA AL-172 Kim S, Abbasi F, Nachmanoff C, Kumar A, Kalra B, Savjani G, Mantzoros C
Weight loss from GLP-1s can also reduce or eliminate arthritis, joint pain, or hypertension
were about creating lasting relationships with our clients, guiding them through their aesthetic journey with expertise and care
The STEP 1 extension data showed that weight regain begins within weeks of dose reduction